Рак не ждет: онколог рассказал о современных возможностях лечения в Украине - Вікна-новини
Рак не ждет: онколог рассказал о современных возможностях лечения в Украине Вікна-новини
3628 материалов по теме, собраны автоматически из проверенных источников
Рак не ждет: онколог рассказал о современных возможностях лечения в Украине Вікна-новини
Kfir Ben-David, M.D., FACS, Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Surgical Oncologist South Florida Hospital News
Matthew David Hall, M.D., MBA, Installed as Endowed Chair in Pediatric Oncology at Baptist Health Herbert Wertheim Cancer Institute | Florida Hospital News and Healthcare Report South Florida Hospital News
Smoking may significantly increase risk for progression and metastases for patients with sarcoma. The findings, presented at the American Society for Radiation Oncology Annual Meeting, showed active smokers had worse outcomes at both 2 years and 5 years, including nearly a twofold greater risk for distant metastases…
Геннадий Онищенко назвал четыре вируса, провоцирующих развитие рака Главный Региональный
«Огурцы вызывают рак»: Врач раскрыла, почему это не сенсация Главный Региональный
Kriti Ahuja, M.D., Joins Baptist Health Wertheim Cancer Institute as a Breast Medical Oncologist South Florida Hospital News
Spencer Streit, D.O., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist and Hematologist | Florida Hospital News and Healthcare Report South Florida Hospital News
Fellowship-Trained Neuro-Oncologist Nishika Karbhari, M.D., Joins Baptist Health Herbert Wertheim Cancer Institute South Florida Hospital News
Nathan J. Nordmann, M.D., Joins Baptist Health Miami Neuroscience Institute as Director of Spinal Oncology and Co-Director of Spinal Radiosurgery South Florida Hospital News
AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video markets.businessinsider.com
AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video StreetInsider
A 39-patient exploratory analysis reported 34.8 months’ median survival in pancreatic cancer. Stock Titan
AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video FinancialContent